Indivior Pharmaceuticals (INDV) Debt to Equity (2022 - 2025)
Historic Debt to Equity for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to -$1.56.
- Indivior Pharmaceuticals' Debt to Equity changed N/A to -$1.56 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.56, marking a year-over-year change of. This contributed to the annual value of -$0.99 for FY2024, which is 2424.33% up from last year.
- According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Debt to Equity is -$1.56.
- In the past 5 years, Indivior Pharmaceuticals' Debt to Equity ranged from a high of $4.71 in Q4 2022 and a low of -$1.56 during Q3 2025
- In the last 4 years, Indivior Pharmaceuticals' Debt to Equity had a median value of -$1.21 in 2025 and averaged -$0.26.
- Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 12771.74% in 2023, then surged by 2424.33% in 2024.
- Indivior Pharmaceuticals' Debt to Equity (Quarter) stood at $4.71 in 2022, then crashed by 127.72% to -$1.3 in 2023, then rose by 24.24% to -$0.99 in 2024, then tumbled by 57.42% to -$1.56 in 2025.
- Its Debt to Equity was -$1.56 in Q3 2025, compared to -$1.27 in Q2 2025 and -$1.15 in Q1 2025.